GuidelineClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Spanish Society for Radiation Oncology and Spanish Society of Medical Physicists recommendations on reirradiation in gynecological cancer: reirradiation techniques, survival outcomes, dose, and toxicity.
Guideline in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Reirradiation in gynecological cancer presents significant clinical challenges due to the complexities of prior treatments and anatomical constraints. In response to the lack of standardized protocols, a Delphi-based consensus was conducted by the GINECOR group of the Spanish Society of Radiation Oncology (SEOR) and the Spanish Society of Medical Physics (SEFM). A multidisciplinary panel of radiation oncologists and medical physicists developed expert-based recommendations through a structured tow-round process. Key findings emphasize the pivotal role of brachytherapy for central and vaginal recurrences and support the use of stereotactic body radiation therapy (SBRT) for nodal disease. Other modalities such as intraoperative radiotherapy and proton therapy are considered in specialized settings. The consensus highlights the importance of individualized treatment planning, especially regarding cumulative dose constraints and organ-at-risk tolerance. Futhermore, it underscores the need for further research and prospective clinical trials to refine treatment indications and optimize outcomes in this clinical context.
Indexed as
Identifiers
40587029What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.